| Period Ending | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|
|
Total Revenue
|
7,504,000
|
7,204,000
|
7,059,000
| | Cost of Revenue | 4,860,000 | 4,564,000 | 4,486,000 | | |
Gross Profit
|
2,644,000
|
2,640,000
|
2,573,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 15,000 | 7,000 | 25,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 1,713,000 | 1,592,000 | 1,524,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
916,000
|
1,041,000
|
1,024,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (56,000) | (148,000) | (89,000) |
|
Earnings Before Interest And Taxes | 860,000 | 893,000 | 935,000 |
|
Interest Expense | 907,000 | 963,000 | 877,000 |
|
Income Before Tax | (47,000) | (70,000) | 58,000 |
|
Income Tax Expense | 257,000 | 299,000 | 295,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (359,000) | (512,000) | (322,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(304,000)
|
(369,000)
|
(237,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(304,000)
|
(369,000)
|
(237,000)
|
|
1.77%